Find clinical trials for COPD. Search for COPD clinical trials in different cities and states across the United States.
Sponsor:
AstraZeneca
Location:
Code:
NCT06040086
Conditions
Chronic Obstructive Pulmonary Disease (COPD)
Eligibility Criteria
Sex: All
Age: 40 - 70+
Healthy Volunteers: Not accepted
Interventions
Placebo
Tozorakimab
Sponsor:
Virginia Commonwealth University
Location:
Code:
NCT05605548
Conditions
Chronic Obstructive Pulmonary Disease
Eligibility Criteria
Sex: All
Age: 40+
Healthy Volunteers: Not accepted
Interventions
MitoQ
Placebo
Sponsor:
Brigham and Women's Hospital
Location:
Code:
NCT06538376
Conditions
Pulmonary Edema
Pneumonia
Atelectasis
Pleural Effusion
Acute Rejection of Lung Transplant (Disorder)
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Portable Dynamic Digital Radiography (DDR)
Sponsor:
AstraZeneca
Location:
Code:
NCT05166889
Conditions
Chronic Obstructive Pulmonary Disease (COPD)
Eligibility Criteria
Sex: All
Age: 40 - 70+
Healthy Volunteers: Not accepted
Interventions
Tozorakimab
Placebo
Sponsor:
ReAlta Life Sciences, Inc.
Location:
Code:
NCT06175065
Conditions
Acute Exacerbation of Chronic Obstructive Pulmonary Disease
Eligibility Criteria
Sex: All
Age: 30+
Healthy Volunteers: Not accepted
Interventions
RLS-0071
Placebo
Sponsor:
JHSPH Center for Clinical Trials
Location:
Code:
NCT06376994
Conditions
Chronic Obstructive Pulmonary Disease (COPD)
Eligibility Criteria
Sex: All
Age: 40+
Healthy Volunteers: Not accepted
Interventions
Air cleaner
Sham air cleaner
Sponsor:
Pulmonx Corporation
Location:
Code:
NCT06035120
Conditions
Emphysema, Pulmonary
Emphysema or COPD
Eligibility Criteria
Sex: All
Age: 22 - 70+
Healthy Volunteers: Not accepted
Interventions
AeriSeal System
Sponsor:
VA Office of Research and Development
Location:
Code:
NCT05701982
Conditions
COPD
Chronic Musculoskeletal Pain
Eligibility Criteria
Sex: All
Age: 40 - 70+
Healthy Volunteers: Not accepted
Interventions
Every Step Counts-Tai Chi
Usual Care
Sponsor:
Paul Szabolcs
Location:
Code:
NCT03500731
Conditions
Idiopathic Pulmonary Fibrosis
Emphysema or COPD
Eligibility Criteria
Sex: All
Age: 18 - 60
Healthy Volunteers: Not accepted
Interventions
CD3/CD19 negative hematopoietic stem cells
Rituximab
Alemtuzumab
Fludarabine
Thiotepa
COPD clinical trials are research studies aimed at evaluating new treatments, interventions, or management strategies for Chronic Obstructive Pulmonary Disease (COPD). These trials aim to discover more effective ways to alleviate symptoms, slow disease progression, and improve the quality of life for individuals living with COPD.
Clinical trials play a vital role in COPD research, offering the most reliable method to test the safety and effectiveness of new therapies. Through these studies, researchers can identify better ways to manage COPD, uncover insights into its pathophysiology, and potentially find a cure.
Types of COPD clinical trials include a wide range of studies focused on improving treatment and management of the disease. These trials test new medications and inhaler technologies, assess physical therapy and rehabilitation programs, explore oxygen and ventilatory support options, evaluate the effectiveness of surgical and interventional procedures, and examine lifestyle and behavioral changes. Each type of trial aims to find better ways to manage COPD symptoms, enhance patient quality of life, and slow disease progression.
These trials evaluate new drugs or combinations of medications administered through inhalers, aiming to reduce the frequency of COPD flare-ups, improve lung function, and alleviate symptoms. They often explore the efficacy of bronchodilators, corticosteroids, and other pharmacological treatments in managing COPD.
Rehabilitation trials investigate the benefits of physical therapy programs, including exercises designed to enhance respiratory function, increase stamina, and improve overall physical fitness in COPD patients. These studies assess how rehabilitation impacts the quality of life, exercise tolerance, and disease progression.
These studies explore the effectiveness of supplemental oxygen therapy and mechanical ventilatory support in individuals with COPD, particularly those with severe disease. Trials may investigate the optimal timing, delivery methods, and outcomes of using oxygen therapy and non-invasive ventilation to manage chronic respiratory failure.
Trials exploring surgical and interventional procedures assess the outcomes of surgical and minimally invasive procedures, such as lung volume reduction surgery (LVRS), bullectomy, or endobronchial valve placement. These studies aim to determine how well these interventions improve breathing, reduce symptoms, and enhance the quality of life for patients with advanced COPD.
Lifestyle and behavioral modification trials examine the impact of dietary changes, smoking cessation, stress management and other lifestyle interventions on COPD management. They investigate how behavioral interventions can affect disease progression, symptom control, and overall well-being.
Individuals diagnosed with COPD at various stages of the disease may be eligible to participate in clinical trials. Eligibility criteria vary depending on the study's objectives and may include factors like age, smoking history, severity of COPD, and current treatments. Some trials may specifically seek participants with certain COPD characteristics or those who have not responded to standard treatments.
Participants in a COPD clinical trial can expect a comprehensive process that begins with eligibility screening and informed consent. During the trial, participants may receive new treatments or interventions and undergo regular monitoring, including medical assessments, lung function tests, and questionnaires about their symptoms and quality of life. Trials are conducted under strict safety protocols, with participants' health and well-being as the top priority.
Enrolling in a COPD clinical trial through our platform is a straightforward and user-friendly process. Here's how to get started: